American Healing

American Healing Technologies (AHT) is a biotechnology company focused on the research and development of botanical drugs and modernized Traditional Chinese Medicine (TCM). The company specializes in creating standardized, evidence-based therapies for oncology supportive care and infectious diseases. AHT's lead product candidate, AHT-101, is a botanical formulation designed to treat radiation-induced oral mucositis and has reached Phase 2 clinical development. The company employs a proprietary extraction and purification platform to ensure the consistency and safety of its complex plant-derived mixtures. By integrating ancient botanical knowledge with modern pharmaceutical standards, AHT aims to provide effective supportive therapies for patients undergoing intensive cancer treatments.